Share Prices & Company Research


17 January 2019

Redmayne Bentley’s Top Trades

Below we take a look at the most frequently traded shares through Redmayne Bentley over the last couple of weeks and consider why they have been so popular.
Index: FTSE All 100
Sector: General Retailers
Market Capitalisation: £2,117.42m
The fast fashion retailer, Boohoo, recently upgraded its full-year sales forecast following a strong period of performance. Sales were up 44% compared to the same period last year, while gross margins rose by 1.7% to 54.2%. This was despite investor fears that profits may have been sacrificed for sales due to heavy discounting over the Black Friday and Christmas period. This impressive performance is in contrast to larger rival ASOS, whose shares fell almost 40% following a warning on profits prior to Christmas following misjudged Black Friday discounts.
Index: FTSE 250
Sector: Mining
Market Capitalisation: £1,047.68m
Sirius Minerals lost one third of its value in September, following its announcement of a significant increase in capital costs. The company stated that it needed a further US$400m - US$600m in financing to complete the development of its large potash project. However, since then, around 87% of the capital cost of the project has been procured. Sirius has also bought a 30% stake in a Brazilian distributor, thus securing a route to market for its fertilizer product. Cibra will purchase 2.5m tonnes of potash per year from Sirius.
Index: FTSE 100
Sector: Pharmaceuticals & Biotechnology
Market Capitalisation: £73,692.47m
GSK recently announced its new joint venture with Pfizer, as the two pharmaceutical giants look to combine their consumer healthcare businesses. GSK CEO Emma Walmsley plans to break up GSK, separating the consumer side of the business from the pharma business. She is betting that the cash-generative nature of the consumer business will be able to support the “number one priority – pharma”. The market responded to the news with GSK shares up 7%, however, this was not enough to make up the £5bn wiped off GSK’s market value following the scrutinised acquisition of Tesaro.
Top Trades is published every fortnight in Equity Insight, a newsletter written by our stockbrokers and investment managers. It provides market commentary, a focus on individual sectors, technical analysis, potential trading opportunities and share reviews.
Please note that investments and income arising from them can fall as well as rise in value and you may lose some or all of the amount you have invested. Past performance and forecasts are not a reliable indicator of future results or performance. Please note that this communication is for information only and does not constitute a recommendation to buy or sell the shares of the companies mentioned.
Redmayne Bentley’s Top Trades
Continuing our Personal Service: View our Latest COVID-19 Update: 11th June 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.